Reviewed by Peptide Treatments Medical Advisory Board
Vesilute: Research & Evidence
Early-Stage ResearchPublished research, clinical trial data, and evidence grading for Vesilute across studied indications.
Back to Vesilute overviewResearch Summary
Vesilute has zero PubMed-indexed human studies, zero RCTs, and no Western clinical trials. All efficacy claims derive from Russian-language animal studies that have not been independently replicated. Established cardiovascular medications with extensive human evidence exist for vascular conditions.
Evidence by Indication (2 indications)
| Indication | Tier | Trials | Summary |
|---|---|---|---|
| Vascular health | Tier D | 0 | No human trials exist; rodent studies report vascular function improvements but remain unverified |
| Immune modulation | Tier D | 0 | Animal data suggests immune parameter changes but no human translation has been attempted |
Graded using our evidence tier methodology.
Research Gap Score /10
Higher score = larger gap between therapeutic potential and available clinical evidence.